Raleigh E Malik (Raleigh Malik)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Roux En Y Gastric Bypass

Randomized Controlled Trial

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Carel W le Roux, Emily R Hankosky, Duzhe Wang, Raleigh E Malik, Maria Yu, Ana Hickey, Hong Kan, Mathijs C Bunck, Adam Stefanski, Luis-Emilio Garcia-Perez, Sean Wharton
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison. Diabetes, obesity & metabolism (2023)
Juan Pablo Frias, Enzo Bonora, David A Cox, M Angelyn Bethel, Anita Y M Kwan, Sohini Raha, Raleigh E Malik
Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD-11. Diabetes, obesity & metabolism 23 (12) (2021)
Enzo Bonora, Juan P Frias, Francisco J Tinahones, Joanna Van, Raleigh E Malik, Zhuoxin Yu, Reema Mody, Angelyn Bethel, Anita Y M Kwan, David A Cox
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD-11. Diabetes, obesity & metabolism 23 (10) (2021)